India telmisartan market is forecasted
to grow at
a steady pace during the forecast period. The India telmisartan market is
driven by surging population with cardiovascular and heart associated disorders
in India. Additionally, continuous government initiatives for spreading awareness about blood
pressure disorders among the citizens is another major factor which is
projected to bolster the market growth. Also, new product developments by the
key market players is further expected to boost the demand through FY2026.
The India telmisartan market is
segmented based on indication, composition, form, route of administration, source,
distribution channel, end user,
company, and region. Based on composition, the market can be segmented into single
and combinational. The combinational segment is expected to register highest
CAGR in the market over the next 5 years which is accredited to increased
efficacy and reduced side effects of combinational drugs. Along with this, it
further aids in reducing the development of multiple drug resistance by the
bacteria, which is further boosting the segmental growth in near future.
The major players operating in the
India telmisartan market are Astellas Pharma India Pvt. Ltd., Boehringer
Ingelheim India Pvt. Ltd., Novartis India Ltd., Venus Remedies Ltd., Candomed
Pharmaceuticals India Pvt. Ltd, Torrent Pharmaceuticals Ltd., Cipla Limited
(Exelan Pharmaceuticals), Lupin Laboratories Ltd., Mylan Laboratories Ltd., Glenmark
Pharmaceuticals Ltd., Astellas Pharma India Pvt. Ltd., and others. Major
companies are developing advanced technologies, receiving approvals from
regulatory bodies, and launching new products in order to stay competitive in
the market. Other competitive strategies include mergers & acquisitions and
new product developments.
Years considered for this report:
Historical Years: FY2016-FY2019
Base Year: FY2020
Estimated Year: FY2021
Forecast Period: FY2022–FY2026
Objective of the
Study:
- To analyze and estimate the market size of India
telmisartan market from FY2016 to FY2019.
- To estimate and forecast the market size of India
telmisartan market from FY2020 to FY2026 and growth rate until FY2026.
- To classify and forecast India telmisartan market
based on indication, composition, form, route of administration, source,
distribution channel, end user, company, and regional distribution.
- To identify dominant region or segment in the India
telmisartan market.
- To identify drivers and challenges for India telmisartan
market.
- To examine competitive developments such as
expansions, new product launches, mergers & acquisitions, etc., in India
telmisartan market.
- To identify and analyze the profile of leading
players operating in India telmisartan market.
- To identify key sustainable strategies adopted
by market players in India telmisartan market.
Click here to download the sample
TechSci Research performed both primary as well as
exhaustive secondary research for this study. Initially, TechSci Research
sourced a list of manufacturers across the globe. Subsequently, TechSci
Research conducted primary research surveys with the identified companies.
While interviewing, the respondents were also enquired about their competitors.
Through this technique, TechSci Research could include the manufacturers which
could not be identified due to the limitations of secondary research. TechSci
Research analyzed the manufacturers, distribution channels and presence of all
major players across the globe.
TechSci Research calculated the market size of India Telmisartan market using a bottom-up approach, wherein data for various end-user segments
was recorded and forecast for the future years. TechSci Research sourced these
values from the industry experts and company representatives and externally
validated through analyzing historical data of these product types and
applications for getting an appropriate, overall market size. Various secondary
sources such as company websites, news articles, press releases, company annual
reports, investor presentations and financial reports were also studied by
TechSci Research.
Key Target Audience:
- Telmisartan manufacturers/
suppliers/ distributors
- Market research and
consulting firms
- Government bodies such as
regulating authorities and policy makers
- Organizations, forums and
alliances related to telmisartan
The study is useful in providing answers
to several critical questions that are important for the industry stakeholders
such as manufacturers, suppliers and partners, end users, etc., besides
allowing them in strategizing investments and capitalizing on market
opportunities.
Report Scope:
In this report, India telmisartan market has
been segmented into following categories, in addition to the industry trends
which have also been detailed below:
- India Telmisartan Market, By Indication:
- Hypertension
- Cardiac Arrest
- Stroke
- Others
- India Telmisartan Market, By Composition:
- India Telmisartan Market, By Form:
- Tablet
- Capsule
- Injection
- Others
- India Telmisartan Market, By Route of
Administration:
- India Telmisartan Market, By Source:
- In-house
- Contract Manufacturing Organizations
- India Telmisartan Market, By Distribution Channel:
- India Telmisartan Market, By End User:
- India Telmisartan Market, By Region:
Competitive
Landscape
Company Profiles: Detailed analysis of the major
companies present in India telmisartan market.
Available
Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed
analysis and profiling of additional market players (up to five).
India telmisartan market is
an upcoming report to be released soon. If you wish an early delivery of this
report or want to confirm the date of release, please contact us at [email protected]